Company / Net Income
Compass Therapeutics, Inc. Net Income History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$49.4M
FY2024
5-year range
-$82.2M / -$29.5M
FY2020-FY2024
Trend
-16.2%
vs FY2023
Sector context
#83 of 216
Health Care
What the data says
At -$49M, Compass Therapeutics, Inc.'s net income ranks #83 of 216 in the Health Care sector. Net Income has fluctuated over the past 7 years, ranging from -$82M in FY2021 to -$36,037 in FY2018.
Based on SEC 10-K filings.
-$49M in FY2024.
Declined from -$39M to -$49M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 216 in Health CareTop 38% of 216This company -$49.4M Sector average $454.3M
▼
-110.9% below sector average
Key checks
Key Insights
- In FY2024, net income decreased 16.2% year-over-year.
- Ranks #83 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$49.4M | -16.2% |
| FY2023 | -$42.5M | -8.3% |
| FY2022 | -$39.2M | +52.3% |
| FY2021 | -$82.2M | -178.6% |
| FY2020 | -$29.5M | +15.1% |
| FY2019 | -$34.7M | -96312.0% |
| FY2018 | -$36.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026